The Effectiveness of an Educational Intervention to Introduce Adolescents From Marginalized Backgrounds to Dermatology: A Pilot Initiative [0.03%]
一项针对边缘背景青少年介绍皮肤病学的教育干预措施的有效性：一次试点倡议
Heli Patel,Hrushikesh Patel,Ross O&#x;Hagan et al.
Heli Patel et al.
Odds of Developing Frontal Fibrosing Alopecia More Closely Tied to Affluence Than Race-a Retrospective Cohort Study [0.03%]
社会经济状况而非种族是 frontal fibrosing alopecia 的危险因素：回顾性队列研究
Jiana Wyche,Derek A Tsang,Crystal Aguh
Jiana Wyche
Kailyn Valido,Luiza Kalil,Danielle Peterson et al.
Kailyn Valido et al.
Reduced liver disease incidence in psoriasis patients treated with interleukin-23 inhibitors: A longitudinal cohort analysis [0.03%]
白细胞介素-23抑制剂治疗组银屑病患者的肝病发病率降低：纵向队列分析
Arjun Mahajan,Sheela S Reddy,Evan W Piette
Arjun Mahajan
Ethical considerations of accommodations in psychological management of alopecia areata [0.03%]
脱发的心理管理中的伦理考量
Aarushi K Parikh,Catherine Taghizadeh,Carolyn Goh et al.
Aarushi K Parikh et al.
Chase Pitchford,Anuj Kunadia,Landon Hendrickson et al.
Chase Pitchford et al.
Enhanced metastatic risk stratification for Cutaneous Squamous Cell Carcinoma by combining clinical guidelines with the Erasmus MC model: Results from Two Nationwide Nested Case-Control Studies [0.03%]
通过结合临床指南和Erasmus MC模型来改善皮肤鳞状细胞癌的转移风险分层：两项全国性病例对照研究的结果
O F M Steijlen,L Pozza,J J H Traets et al.
O F M Steijlen et al.
Background: Reliably assessing metastatic risk in cutaneous squamous cell carcinoma (CSCC) remains clinically challenging despite established guidelines. ...
Skin Clearance, Duration of Treatment-free Interval, and Safety of Tapinarof Cream 1% Once Daily: Results from ADORING 3, a 48-week Phase 3 Open-label Extension Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis [0.03%]
1%塔匹纳福霜每日一次治疗的皮肤 clearance、无治疗间隔持续时间和安全性：ADORING 3 扩展研究（成人和年仅 2 岁儿童中特应性皮炎患者的 48 周开放标签研究）
Robert Bissonnette,Linda Stein Gold,Leon Kircik et al.
Robert Bissonnette et al.
Background: In two pivotal phase 3 trials, tapinarof demonstrated significant efficacy and was well tolerated in patients down to age 2 years with atopic dermatitis. ...
The Impact of Lifestyle Factors on Cardiometabolic Comorbidities and Mortality of Psoriatic Diseases: A Multi-State Model Analysis [0.03%]
生活方式因素对银屑病心血管代偿性病变和死亡率影响的多状态模型分析
Yi Xiao,Songchun Yang,Yang Zhang et al.
Yi Xiao et al.
Background: The role of lifestyle factors in the progression of psoriatic diseases (PD) and cardiometabolic diseases (CMD) remains underexplored. Objectiv...
Use of Janus kinase inhibitors in patients aged ≤18 years with alopecia areata: A systematic review and meta-analysis [0.03%]
Janus激酶抑制剂治疗≤18岁儿童及青少年斑秃患者的安全性和有效性系统评价和meta分析
Kejia Xu,Gu He,Zhongyue Deng et al.
Kejia Xu et al.